0
Sign In  | Subscribe

Endocrine and Metabolism Collection
 41-60 of 103 Articles
ACP Journal Club |  15 February 2011
Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes
PDFPDF
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(4):JC2-13. doi:10.7326/0003-4819-154-4-201102150-02013
ACP Journal Club |  16 November 2010
Intensive glucose control did not reduce a composite of microvascular events more than standard control in type 2 diabetes
PDFPDF
David C. Aron, MD, MS; Leonard M. Pogach, MD, MBA
Ann Intern Med. 2010;153(10):JC5-9. doi:10.7326/0003-4819-153-10-201011160-02009
ACP Journal Club |  16 November 2010
Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes
PDFPDF
David L. Bronson, MD, FACP
Ann Intern Med. 2010;153(10):JC5-10. doi:10.7326/0003-4819-153-10-201011160-02010
ACP Journal Club |  19 October 2010
Prior intensive insulin treatment reduced long-term risk for peripheral neuropathy in type 1 diabetes
PDFPDF
Mario Di Napoli, MD
Ann Intern Med. 2010;153(8):JC4-3. doi:10.7326/0003-4819-153-8-201010190-02003
ACP Journal Club |  19 October 2010
Aspirin alone or combined with nadroparin did not increase live birth rates in women with unexplained recurrent miscarriage
PDFPDF
Christopher J. Robinson, MD, MSCR
Ann Intern Med. 2010;153(8):JC4-7. doi:10.7326/0003-4819-153-8-201010190-02007
ACP Journal Club |  19 October 2010
Review: Vibration testing and monofilament testing are most accurate for diagnosing large-fiber peripheral neuropathy in diabetes
PDFPDF
David R. Gutknecht, MD
Ann Intern Med. 2010;153(8):JC4-10. doi:10.7326/0003-4819-153-8-201010190-02010
ACP Journal Club |  21 September 2010
Review: Treatment for gestational diabetes reduces risk for shoulder dystocia
PDFPDF
Debra A. Guinn, MD
Ann Intern Med. 2010;153(6):JC3-6. doi:10.7326/0003-4819-153-6-201009210-02006
ACP Journal Club |  17 August 2010
HbA1c levels ≤ 5.5% ruled out, and levels ≥ 7.0% ruled in, type 2 diabetes in clinical and community populations
PDFPDF
Leonard Reeves, MD, FAAFP
Ann Intern Med. 2010;153(4):JC2-11. doi:10.7326/0003-4819-153-4-201008170-02011
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
PDFPDF
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  20 July 2010
Fenofibrate plus simvastatin did not prevent major CV events more than simvastatin alone in type 2 diabetes
PDFPDF
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-5. doi:10.7326/0003-4819-153-2-201007200-02005
ACP Journal Club |  20 July 2010
Review: Metformin does not increase risk for lactic acidosis in type 2 diabetes
PDFPDF
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2010;153(2):JC1-9. doi:10.7326/0003-4819-153-2-201007200-02009
ACP Journal Club |  20 July 2010
Lasofoxifene reduced vertebral fractures in postmenopausal women with osteoporosis
PDFPDF
Carolyn J. Crandall, MD, MS
Ann Intern Med. 2010;153(2):JC1-11. doi:10.7326/0003-4819-153-2-201007200-02011
ACP Journal Club |  20 July 2010
Higher “normal” glycated hemoglobin levels were associated with increased risk for diabetes, CVD, stroke, and mortality in adults
PDFPDF
Steven A. Smith, MD
Ann Intern Med. 2010;153(2):JC1-13. doi:10.7326/0003-4819-153-2-201007200-02013
ACP Journal Club |  15 June 2010
Review: Statin use increases risk for diabetes
PDFPDF
John-Michael Gamble, BScPharm, MSc; Sumit R. Majumdar, MD, MPH
Ann Intern Med. 2010;152(12):JC6-7. doi:10.7326/0003-4819-152-12-201006150-02007
ACP Journal Club |  15 June 2010
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
PDFPDF
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-9. doi:10.7326/0003-4819-152-12-201006150-02009
ACP Journal Club |  15 June 2010
Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors
PDFPDF
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-10. doi:10.7326/0003-4819-152-12-201006150-02010
ACP Journal Club |  18 May 2010
Intensive insulin therapy did not reduce mortality more than conventional therapy in septic shock treated with corticosteroids
PDFPDF
Katherine J. Deans, MD; Peter C. Minneci, MD
Ann Intern Med. 2010;152(10):JC5-5. doi:10.7326/0003-4819-152-10-201005180-02005
ACP Journal Club |  20 April 2010
Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis
PDFPDF
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-2. doi:10.7326/0003-4819-152-8-201004200-02002
ACP Journal Club |  20 April 2010
Review: Current evidence shows no overall benefit of aspirin for primary prevention of cardiovascular disease in diabetes
PDFPDF
Michael LeFevre, MD, MSPH
Ann Intern Med. 2010;152(8):JC4-10. doi:10.7326/0003-4819-152-8-201004200-02010
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
PDFPDF
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)